Pearinda 4 mg (Perindopril)

Reason for recall

This recall is initiated because Pharma Dynamics (Pty) Ltd, as a consequence of a printing error identified on the outer carton of the affected batch. The outer carton of the Pearinda 4 reflects the active ingredient erroneously printed as Perindopril tert-butylamine 8 mg instead of Perindopril tert-butylamine 4 mg.

Advice to HCPs/Distributors/Public

Pharma Dynamics (Pty) Ltd request that you refrain from selling the affected batch of Pearinda 4 (Batch number 002120) and return stock to your supplying warehouse or distributor with immediate effect. For further product information, please call Pharm Dynamics (Pty) Ltd on 021 707 7000 or email pharmacovigilance@pharmadynamics.co.za.

Proposed action taken and its urgency: A SAHPRA approved recall letter was distributed to all distribution points, and the recall process was started.

Reporting side effects

Public and healthcare professionals are encouraged to report any side effects after using a health product or after immunisation by using the Med Safety App. Your report will contribute to our monitoring of these health products.